Nancy Wysenski - 09 May 2023 Form 4 Insider Report for Alkermes plc. (ALKS)

Role
Director
Signature
/s/ Shantale Greenson, attorney-in-fact for Nancy J. Wysenski
Issuer symbol
ALKS
Transactions as of
09 May 2023
Net transactions value
-$4,674
Form type
4
Filing time
10 May 2023, 16:34:10 UTC
Previous filing
27 Apr 2023
Next filing
18 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALKS Ordinary Shares Options Exercise $1,089,550 +35,000 +221% $31.13 50,829 09 May 2023 Direct F1
transaction ALKS Ordinary Shares Options Exercise $194,562 +6,250 +12% $31.13 57,079 09 May 2023 Direct F1
transaction ALKS Ordinary Shares Sale $1,288,786 -41,250 -72% $31.24 15,829 09 May 2023 Direct F1, F2
holding ALKS Ordinary Shares 11,242 09 May 2023 The Nancy J. Wysenski Revocable Trust F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALKS Non Qualified Stock Option (Right to Buy) Options Exercise $0 -35,000 -100% $0.000000* 0 09 May 2023 Ordinary Shares 35,000 $31.13 Direct F1, F4
transaction ALKS Non Qualified Stock Option (Right to Buy) Options Exercise $0 -6,250 -100% $0.000000* 0 09 May 2023 Ordinary Shares 6,250 $31.13 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This exercise and sale of options was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2023. These options were scheduled to expire on May 15, 2023.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.23 to $31.33. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request.
F3 The reporting person is a trustee and a beneficiary of The Nancy J. Wysenski Revocable Trust, established on September 23, 2014 ("The Nancy J. Wysenski Revocable Trust").
F4 These options are fully vested in accordance with their terms.